|
|
|
42
|
A801X
|
ARIMIDEX 1MG TAB (AZN) ANASTROZOLE (C)
|
ANASTROZOLE
|
ARIMIDEX
|
28'S
|
C
|
135.92
|
4.85
|
TAB
|
30
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A8317
|
MOBIC 15MG TAB (BOE/STO) MELOXICAM
|
MELOXICAM
|
MOBIC
|
30'S
|
C
|
41.59
|
1.39
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A831AB
|
ARCOXIA 60MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.46
|
1.75
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831AB
|
ARCOXIA 60MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.68
|
1.763
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A831AB
|
ARCOXIA 60MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.68
|
1.76
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
40
|
A831AD
|
ARCOXIA 90MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.18
|
1.94
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A831AD
|
ARCOXIA 90MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.43
|
1.96
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
40
|
A831AF
|
ARCOXIA 120MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
48.52
|
3.47
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831AF
|
ARCOXIA 120MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
49.01
|
3.5008
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A831AF
|
ARCOXIA 120MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
49.01
|
3.50
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A831AK
|
APO-MELOXICAM 7.5MG TAB (APO)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
4.62
|
0.05
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831AN
|
APO-MELOXICAM 15MG TAB (APO/COL)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.61
|
0.08
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A831AN
|
APO-MELOXICAM 15MG TAB (APO)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.77
|
0.08
|
TAB
|
15
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831AZ
|
MELOXICAM 15MG TAB (HEA) (C)
|
MELOXICAM
|
MELOXICAM
|
10'S
|
C
|
0.71
|
0.0707
|
TAB
|
15
|
BOTT
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831BB
|
CELEBREX 200MG CAP (PFI/STO) CELECOXIB
|
CELECOXIB
|
CELEBREX
|
30'S
|
C
|
54.48
|
1.82
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831BB
|
CELEBREX 200MG CAP (PFI) CELECOXIB (C)
|
CELECOXIB
|
CELEBREX
|
30'S
|
C
|
54.96
|
1.8322
|
CAP
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
40
|
A831BW
|
CELEBREX 200MG CAP (PFI/SBI) CELECOXIB
|
CELECOXIB
|
CELEBREX
|
30'S
|
C
|
54.48
|
1.82
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831BW
|
CELEBREX 200MG CAP (PFI) CELECOXIB (C)
|
CELECOXIB
|
CELEBREX
|
30'S
|
C
|
54.96
|
1.8322
|
CAP
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
41
|
A831DG
|
ARCOXIA 90MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.43
|
1.9591
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831EV
|
APO-CELECOXIB 200MG CAP (APO/COL)
|
CELECOXIB
|
APO-CELECOXIB
|
100'S
|
C
|
17.40
|
0.17
|
CAPSULE
|
0
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|